Thyroid cancer rates and 131i doses from nevada atmospheric nuclear bomb tests: An update

Radiation Research

Volumn 173, Issue 5, 2010, Pages 659-664

  Gilbert, Ethel S ^a   Huang, Lan ^b   Bouville, Andre ^a   Berg, Christine D ^c   Ron, Elaine ^a  

^a Department of Health and Human Services ^*  (United States)

^b Center for Drug Evaluation and Research   (United States)

^c Early Detection Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; ARTICLE; ATOMIC BOMB; CANCER INCIDENCE; CANCER RISK; CHILD; FALLOUT; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; SCHOOL CHILD; SEX DIFFERENCE; THYROID CANCER; UNITED STATES;

FEMALE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; NEOPLASMS, RADIATION-INDUCED; NEVADA; NUCLEAR WARFARE; RADIATION DOSAGE; THYROID NEOPLASMS;

EID: 77951820863     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2057.1     Document Type: Article

References (23)

1. National Cancer Institute (NCI), Estimated Exposures and Thyroid Doses Received by the American People from Iodine-131 in Fallout Following Nevada Atmospheric Nuclear Bomb Tests, a Report from the National Cancer Institute. U.S. Department of Health and Human Services, Washington, DC, 1997.
2. E. Ron, J. H. Lubin, R. E. Shore, K. Mabuchi, B. Modan, L. M. Pottern, A. B. Schneider, M. A. Tucker and J. D. Boice, Jr., Thyroid cancer following exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141, 250-277 (1995).
3. 131I in childhood. J. Natl. Cancer Inst. 97, 24-732 (2005).
4. M. D. Tronko, G. R. Howe, T. I. Bogdanova, A. C. Bouville, O. V. Epstein, A. B. Brill, I. Likhtarev, D. J. Fink, V. V. Markov and G. W. Beebe, A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: thyroid cancer in Ukraine detected during first screening. J. Natl. Cancer Inst. 98, 897-903 (2006).
5. 131I doses from atmospheric nuclear bomb tests. J. Natl. Cancer Inst. 90, 1654-1660 (1998).
6. M. Colonna, A. V. Guizard, C. Schvartz, M. Velten, N. Raverdy, F. Molinie, P. Delafosse, B. Franc and P. Grosclaude, A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur. J. Cancer 43, 891-900 (2007).
7. L. Davies and H. G. Welch, Increasing incidence of thyroid cancer in the United States, 1973-2002. J. Am. Med. Assoc. 295, 2164-2167 (2006).
8. L. Enewold, K. Zhu, E. Ron, A. J. Marrogi, A. Stojadinovic, G. E. Peoples and S. S. Devesa, Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol. Biomarkers Prev. 18, 784-791 (2009).
9. R. M. Reynolds, J. Weir, D. L. Stockton, D. H. Brewster, T. C. Sandeep and M. W. Strachan, Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin. Endocrinol. 62, 156-162 (2005).
10. J. R. Burgess, Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 12, 141-149 (2002).
11. E. Lund and M. R. Galanti, Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: An analysisofbirth cohorts. Cancer Causes Control 10, 181-187 (1999).
12. S. J. Cotterill, M. S. Pearce and L. Parker, Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident? Eur. J. Cancer 37, 1020-1026 (2001).
13. J. Rosina, E. Kvasnák, D. Suta, T. Kostrhun and D. Drábová, Czech Republic 20 years after Chernobyl accident. Radiat. Prot. Dosimetry 130, 452-458 (2008).
14. G. S. Wilkinson, Environmental exposure to radioactive iodine and thyroid disease. Epidemiology 17, 599-600 (2006).
15. M.J. Horner, L.A.G. Ries, M. Krapcho, N. Neyman, R. Aminou, N. Howlader, S. F. Altekruse, E. J. Feuer, L. Huangand and B. K. Edwards, Eds., SEER Cancer Statistics Review, 1975-2006. National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
16. D. L. Preston, J. H. Lubin, D. A. Pierce and E. McConney, Epicure User's Guide. Hirosoft International Corporation, Seattle, WA, 1993.
17. D. L. Preston, E. Ron, S. Tokuoka, S. Funamoto, N. Nishi, M. Soda, K. Mabuchi and K. Kodama, Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 168, 1-64 (2007).
18. S. Davis, V. Stepanenko, N. Rivkind, K. J. Kopecky, P. Voilleque, V. Shakhtarin, E. Parshkov, S. Kulikov, E. Lushnikov and A. Tsyb, Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat. Res. 162, 241-248 (2004).
19. S. Davis, K. J. Kopecky, T. E. Hamilton and L. Onstad, Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. J. Am. Med. Assoc. 292, 2600-2613 (2004).
20. C. E. Land, Z. Zhumadilov, B. I. Gusev, M. H. Hartshorne, P. W. Wiest, P. W. Woodward, L. A. Crooks, N. K. Luckyanov, C. M. Filimore and S. L. Simon, Ultrasound-detected thyroid nodule prevalence and radiation dose from fallout. Radiat. Res. 169, 373-383 (2008).
21. J. L. Lyon, S. C. Alder, M. B. Stone, A. Scholl, J. C. Reading, R. Holubkov, X. Sheng, G. L. While, Jr., K. T. Hegmann and A.W. Meikle, Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data. Epidemiology 17, 604-614 (2006).
22. NCRP, Risk to the Thyroid from Ionizing Radiation. Report 159, National Council on Radiation Protection and Measurements, Bethesda, MD, 2009.
23. A. Bouville, S. L. Simon, C. W. Miller, H. L. Beck, L. R. Anspaugh and B. G. Bennett, Estimates of doses from global fallout. Health. Phys. 82, 690-705 (2002).